Diversified Trust CO Novavax Inc Transaction History

Diversified Trust CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 13, 2022	SELL	$134.56 - $217.97 $140,884 - $228,214	-1,047 Closed	0 $0
Q3 2021 Jan 13, 2022	BUY	$177.8 - $270.58 $186,156 - $283,297	1,047 New	1,047 $217,000
Q2 2021 Jul 20, 2021	SELL	$121.0 - $257.67 $571,846 - $1.22 Million	-4,726 Closed	0 $0
Q1 2021 May 10, 2021	BUY	$112.98 - $319.93 $45,756 - $129,571	405 Added 9.37%	4,726 $857,000
Q4 2020 Jan 08, 2021	BUY	$78.74 - $139.5 $340,235 - $602,779	4,321 New	4,321 $482,000

291

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $704M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Diversified Trust CO, based on Form 13F filings with the SEC.

Stay updated on Diversified Trust CO with notifications on news.